CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $707,000 | -27.0% | 41,982 | -0.7% | 0.05% | -30.1% |
| Q1 2018 | $968,000 | -87.2% | 42,269 | -85.5% | 0.07% | -86.8% |
| Q4 2017 | $7,554,000 | +5579.7% | 292,010 | +2352.0% | 0.56% | +6066.7% |
| Q2 2016 | $133,000 | -52.7% | 11,909 | -42.2% | 0.01% | -52.6% |
| Q1 2016 | $281,000 | -90.0% | 20,600 | -86.2% | 0.02% | -90.6% |
| Q4 2015 | $2,823,000 | -36.4% | 148,835 | -37.1% | 0.20% | -35.6% |
| Q3 2015 | $4,439,000 | +192.6% | 236,517 | +107.7% | 0.32% | +211.9% |
| Q4 2014 | $1,517,000 | – | 113,894 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
| INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
| Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
| RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
| Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
| Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
| Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
| KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |